omni
aafp

Company Established In
1986

CATEGORIES & HEADINGSdetails >>

sponsored

JANT Pharmacal Corporation develops and markets medical devices, including point of care and complementary diagnostics.
Established in 1986, the company’s product portfolio includes a comprehensive line of CLIA-waived point-of-care rapid tests and instrumentation for physicians’ offices, clinics, hospitals, laboratory, wellness, clinical research and long term care settings.

Accutest® , Accustrip® and LipidPlus Brand
CLIA-Waived Tests Include:
Pregnancy
Strep A
Infectious mononucleosis
H. pylori Urease and antibody tests
Urinary Tract Infection (UTI)
TSH
Immunological fecal occult blood tests (IFOBT)
Urinalysis readers and strips
Drugs of abuse, alcohol and tobacco
LipidPlus® Total Cholesterol and Glucose Measuring System

In addition, the company is launching a CLIA-waived analyzer that includes Lipid Panels, AST, ALT, Glucose, Creatinine and general chemistry panels.
JANT also offers the physician office and reference lab a suite of clinical chemistry, hematology, immunoassay and urinalysis systems and reagents. Laboratory consultation services are available to assist the laboratory professional in maximizing laboratory efficiency and operational productivity. These services include financial feasibility assessment, work flow optimization, as well as regulatory and proficiency compliance.

Vendor Showcase

RAPID POINT-OF-CARE DIAGNOSTICS

RAPID POINT-OF-CARE DIAGNOSTICS

Jant Pharmacal’s point of care diagnostic product line offers innovative CLIA-waived rapid tests for use in physicians’ offices, clinics, hospitals, urgent care, workplace, criminal justice, drug treatment and laboratory practice settings. Our product line includes urinalysis, coagulation, infectious disease, drugs of abuse and cancer screening. Jant Pharmacal Corporation markets its products under its proprietary registered trademarks: Accutest®, Accustrip® and LipidPlus®. read more